Marvin R. Ellison
Known title: DirectorCIK: 0001350382
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Lowe's Highlights Dividend Status and Black Friday Changes. Lowe's has been highlighted as a dividend champion contender, drawing attention to its stable yield. The retailer announced major Black Friday changes that could shift shopper behavior, while average ticket growth helps offset softer visits. Analysts keep a target range of $190 to $300, reflecting ongoing interest in the company's performance.
Transaction History
| FDX | ▲ Buy | Option Exercise | 5,042 | $695K | 8/28/2026 | View on chart |
| FDX | ▼ Sell | Tax Withholding | 2,097 | $695K | 8/28/2026 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 7,875 | $1.9M | 4/1/2026 | View on chart |
| LOW | ▲ Buy | Grant | 37,292 | $0 | 4/1/2026 | View on chart |
| LOW | ▼ Sell | Open Market | 7,153 | $1.9M | 1/9/2026 | View on chart |
| LOW | ▼ Sell | Open Market | 7,323 | $1.9M | 1/9/2026 | View on chart |
| LOW | ▼ Sell | Open Market | 3,524 | $925K | 1/9/2026 | View on chart |
| FDX | ▲ Buy | Grant | 823 | $0 | 9/29/2025 | View on chart |
| FDX | ▲ Buy | Grant | 295 | $70K | 9/29/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 681 | $181K | 8/20/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 18,060 | $4.8M | 8/20/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 7,241 | $1.9M | 8/20/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 5,408 | $1.4M | 8/20/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 7,009 | $1.8M | 8/20/2025 | View on chart |
| LOW | ▼ Sell | Open Market | 1,601 | $423K | 8/20/2025 | View on chart |
| FDX | ▲ Buy | Option Exercise | 3,610 | $513K | 7/9/2025 | View on chart |
| FDX | ▼ Sell | Open Market | 3,610 | $855K | 7/9/2025 | View on chart |
| LOW | ▲ Buy | Option Exercise | 27,963 | $0 | 4/1/2025 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 18,873 | $4.4M | 4/1/2025 | View on chart |
| LOW | ▲ Buy | Grant | 18,216 | $0 | 4/1/2025 | View on chart |
| FDX | ▲ Buy | Grant | 755 | $0 | 9/23/2024 | View on chart |
| FDX | ▲ Buy | Option Exercise | 2,535 | $407K | 7/11/2024 | View on chart |
| FDX | ▼ Sell | Open Market | 2,535 | $759K | 7/11/2024 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 27,755 | $6.9M | 4/1/2024 | View on chart |
| LOW | ▲ Buy | Grant | 15,044 | $0 | 4/1/2024 | View on chart |
| LOW | ▲ Buy | Option Exercise | 49,601 | $0 | 4/1/2024 | View on chart |
| FDX | ▲ Buy | Grant | 267 | $70K | 9/22/2023 | View on chart |
| FDX | ▲ Buy | Grant | 745 | $0 | 9/22/2023 | View on chart |
| LOW | ▲ Buy | Option Exercise | 110,894 | $0 | 4/1/2023 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 61,271 | $12.3M | 4/1/2023 | View on chart |
| LOW | ▲ Buy | Grant | 18,128 | $0 | 4/1/2023 | View on chart |
| FDX | ▲ Buy | Grant | 954 | $140K | 9/26/2022 | View on chart |
| LOW | ▲ Buy | Option Exercise | 75,220 | $0 | 4/1/2022 | View on chart |
| LOW | ▼ Sell | Tax Withholding | 41,783 | $8.5M | 4/1/2022 | View on chart |
| LOW | ▲ Buy | Grant | 15,224 | $0 | 4/1/2022 | View on chart |
| FDX | ▲ Buy | Grant | 307 | $70K | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking
FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.
FedEx eyes record-high Q4 delivery prices and expands digital pharma booking. FedEx expects delivery rates to reach record highs in the fourth quarter, according to a TD Cowen/AFS note. The company says its recent freight‑spin strategy has improved performance, though pricing is still relatively high. It also launched a digital booking platform for European cold‑chain pharmaceutical shipments to make the process smoother for customers.